Login / Signup

Vagus nerve stimulation therapy in people with drug-resistant epilepsy (CORE-VNS): rationale and design of a real-world post-market comprehensive outcomes registry.

Arjune SenRyan VernerJames P ValerianoRicky LeeMuhammad ZafarRhys ThomasKatarzyna KotulskaEllen JespersMaxine DibuéPatrick Kwannull null
Published in: BMJ neurology open (2021)
NCT03529045.
Keyphrases
  • drug resistant
  • multidrug resistant
  • acinetobacter baumannii
  • health insurance
  • type diabetes
  • cystic fibrosis
  • adipose tissue
  • pseudomonas aeruginosa
  • glycemic control